Cell penetrating peptide

US2022356207A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2022356207-A1
Application numberUS-202217854647-A
CountryUS
Kind codeA1
Filing dateJun 30, 2022
Priority dateDec 11, 2017
Publication dateNov 10, 2022
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An object of the present invention is to provide a cell penetrating peptide having a penetrating ability into cells. The present inventors provided a cell penetrating peptide consisting of the amino acid sequence of SEQ ID NO: 1, a cell penetrating peptide consisting of the amino acid sequence of SEQ ID NO: 2 and a cell penetrating peptide consisting of the amino acid sequence of SEQ ID NO: 3; and a complex comprising any one of the cell penetrating peptide and a functional molecule.

First claim

Opening claim text (preview).

1 . A polynucleotide comprising a nucleotide sequence encoding a peptide consisting of the amino acid sequence of SEQ ID NO: 1. 2 . A polynucleotide comprising a nucleotide sequence encoding the complex comprising the peptide consisting of the amino acid sequence of SEQ ID NO: 1 and a functional molecule, wherein the functional molecule is polypeptides. 3 . A complex comprising the peptide consisting of the amino acid sequence of SEQ ID NO: 1 and a functional molecule, wherein the functional molecule is selected from the group consisting of low molecular compounds, polynucleotides, polypeptides, lipids, carbohydrates, other high molecular compounds, magnetic particles and physiologically active substances. 4 . The complex according to claim 3 , wherein the functional molecule is selected from the group consisting of polynucleotides, polypeptides, lipids, carbohydrates, magnetic particles and liposomes.

Assignees

Inventors

Classifications

  • Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof · CPC title

  • DNA sequences coding for fusion proteins · CPC title

  • C07K7/06Primary

    having 5 to 11 amino acids · CPC title

  • containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP] · CPC title

  • Fusion polypeptide · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2022356207A1 cover?
An object of the present invention is to provide a cell penetrating peptide having a penetrating ability into cells. The present inventors provided a cell penetrating peptide consisting of the amino acid sequence of SEQ ID NO: 1, a cell penetrating peptide consisting of the amino acid sequence of SEQ ID NO: 2 and a cell penetrating peptide consisting of the amino acid sequence of SEQ ID NO: 3; …
Who is the assignee on this patent?
Astellas Pharma Inc, Nat Center For Global Health And Medicine, Univ Hiroshima
What technology area does this patent fall under?
Primary CPC classification C07K7/06. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Nov 10 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).